Clive Corcoran writes that, based on the formations seen on the Nasdaq 100 (NDX) chart, a retreat to the 1500 level would seem like a realistic intermediate-term target.
The S&P 500 has notably failed to take out the 38% retracement level in the region of 1014, and there is a plausible case that suggests that support levels around 950 may have to be tested again.
DBA, a sector fund which allows investors to take a position on agricultural commodities, appears to be preparing for a move up from an ascending wedge pattern, but a more attractive entry position could present itself in coming sessions.
UUP, the ETF which allows investors to profit from recovery of the US dollar against a basket of currencies, is still in a basing pattern, but Clive Corcoran expects the reward/risk on this index to favor the long side in coming weeks.
Teva Pharmaceuticals (TEVA) has a pullback pattern on declining volume and Clive Corcoran thinks it could be a relatively attractive reward/risk proposition on the long side.
Copyright 2024 Tiger Shark Publishing LLC . All rights reserved.
It should not be assumed that the methods, techniques, or indicators presented on these websites will be profitable or that they will not result in losses. Past results are not necessarily indicative of future results. Examples presented on these websites are for educational purposes only. These set-ups are not solicitations of any order to buy or sell. The authors, Tiger Shark Publishing LLC, and all affiliates assume no responsibility for your trading results. There is a high degree of risk in trading.